Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
P2Y12 inhibitors - particularly ticagrelor, but possibly also clopidogrel - may reduce the risk of Staphylococcus aureus bacteremia and potentially improve the course of the disease. The underlying mechanism is likely based on immunomodulatory effects of platelets rather than direct bacterial killing. However, the clinical evidence comes from non-randomized observational studies and primarily involves pa…